Big Early Effects in Immunosuppressive Therapy Predict Better Outcomes

Big Early Effects in Immunosuppressive Therapy Predict Better Outcomes

291705

Big Early Effects in Immunosuppressive Therapy Predict Better Outcomes

Greater reductions in the levels of antibodies against the acetylcholine receptor (AChR) within the first three months after immunosuppressive treatment in people with myasthenia gravis (MG) are associated with better one-year post-therapy outcomes, a study shows. These findings suggest that measuring anti-AChR antibodies shortly after the start of such therapy may be useful for assessing treatment responses and predicting one-year outcomes in MG patients who test positive for these antibodies (AChR-positive MG), the researchers said. The study,…

You must be logged in to read/download the full post.